#ParadigmLost: Psychedelics in Science & Therapy
After nearly 50 years of academic prohibitionism, the interest for psychedelics in the scientific and medical communities is rapidly increasing, once again, driven by state-of the art neuroimaging techniques and striking clinical applications. What more can psychedelics tell us about brain function in the 21st century? How can altered states of consciousness grant therapeutic benefits?
On June 2nd, APRA invites you to Paradigm Lost, our first symposium on psychedelics in science and therapy. From computational neuroscience, to psychology and psychiatry, five international researchers will discuss their most cutting-edge findings, and share their perspectives for future developments.
Selen Atasoy (PhD), University of Oxford
Christopher Timmermann (PhD Cand.), Imperial College London
Timo Torsten Schmidt (PhD), Freie Universität Berlin
Natasha Mason (PhD Cand.) Maastricht University
Tijmen Bostoen (PhD), Leiden University Medical Center
Martin Fortier (PhD Cand.), Institut Nicod, Ecole Normale Supérieure Paris
The symposium will take place at the beautiful venue of the Academisch-cultureel centrum SPUI25 (Spui 25, 1012 WX Amsterdam) and last approximately from 09:30 to 18:00, with breaks between lectures and for lunch.
If you choose a student ticket option, you will be asked for a valid student card at the door. If you would like to request any other special arrangements or have any questions, please contact us directly.
The symposium, like all APRA activities, is not for profit, and is made entirely possible thanks to the work of our volunteer organizers, the support of the ticket holders, and a generous sponsorship from Stichting Toekenningen of the UvA, for which we are very grateful.
Amsterdam Psychedelic Research Association (APRA)
|Adres||Academisch-cultureel centrum SPUI25|
|Datum||2 June 2018|
|Tijd||09:30 - 18:00|